Mitochondrial redox state and the regulation of gluconeogenesis in the isolated, perfused cat liver  by Arinze, Ifeanyi J. & Hanson, Richard W.
Volume 3 1, number 3 FEBS LETTERS May 1973 
MITOCHONDRIAL REDOX STATE AND THE REGULATION OF GLUCONEOGENESIS 
IN THE ISOLATED, PERFUSED CAT LIVER 
Ifeanyi J. ARINZE and Richard W. HANSON * 
Fels Research Institute and the Department of Biochemistry, 
Temple University School of Medicine, Philadelphia, Penn. I91 40, USA 
Received 22 February 1973 
1. Introduction 
Previous studies from this laboratory [l-4] have 
advanced the hypothesis that the oxidation-reduction 
state is a major factor regulating the rate of PEP? for- 
mation by isolated guinea pig, rabbit and human liver 
mitochondria. The difference in the regulation of 
gluconeogenesis in the perfused guinea pig and rabbit 
liver as compared to rat liver [5] underscores the im- 
portance of mitochondrial PEPCK, which makes up 
SO-60% of the total hepatic activity of this enzyme 
in many mammalian species [6,7]. In this paper we 
have tested the influence of redox alterations in the 
mitochondria on the overall rate of glucogenesis in 
the perfused liver of the cat, a non-ruminant carnivor- 
ous animal in which the intracellular distribution of 
hepatic PEPCK [7] is similar to that of the human. 
The results show that, as in guinea pig liver, shifting 
the mitochondrial oxidation-reduction potential 
towards increased reduction inhibits gluconeogenesis. 
The gluconeogenic flux via mitochondrial PEPCK ac- 
counts for at least half of the overall rate of glucose 
production from lactate. 
* Recipient of a Career Development Award (K-4-AM-15365) 
from the United States Public Health Service. 
+ Abbreviations: PEP: phosphoenolpyruvate; 
PEPCK:.phosphoenolpyruvate carboxykinase; 
P-OHB: P-hydroxybutyrate; 
AcAc: acetoacetate. 
2. Methods 
Livers were perfused with a non-recirculating hemo- 
globin-free Krebs-Ringer bicarbonate buffer, pH 7.4, 
as described previously [S] using the Scholz perfusion 
apparatus [8-lo]. The cats weighed 450-700 g and 
were fasted for 48 hr before the experiment. The per- 
fusion protocol is summarized in the legend to fig. 1. 
The oxygen tension in the effluent medium was con- 
tinuously monitored by a Clark-type oxygen electrode. 
Glucose, acetoacetate and P-hydroxybutyrate in the 
perfusate were measured enzymatically as described 
previously [ 51. 
3. Results 
Fig. 1 shows that low concentrations of octanoate 
inhibited glucose production from lactate in the perfused 
cat liver. This inhibition was reversed upon termination 
of the fatty acid infusion. Similar concentrations of 
octanoate have been shown to stimulate gluconeogenesis 
in the perfused rat liver [S]. The inhibition of gluconeo- 
genesis in the perfused cat liver was accompanied by 
an increased production of ketone bodies and by a 2- 
fold increase in the &OHB/AcAc ratio in the perfusate. 
Both the /?-OHB/AcAc ratio and the ketone body level 
in the per&sate fell to control levels when the fatty 
acid infusion was terminated. Subsequently the rate 
of glucose production returned to near control levels. 
A clear-cut association between the intramitochon- 
drial generation of reducing equivalents and inhibition 
of gluconeogenesis is illustrated in fig. 2 in which /3- 
hydroxybutyrate was used as a source of mitochondrial 
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Fig. 1. Effect of octanoate on glucose production from lactate 
by the perfused cat liver. Livers from fasted (48 hr) cats were 
perfused with Krebs-Ringer bicarbonate buffer alone until 
endogenous glucose production was reduced to a minimum 
(0.061 f 0.014 pmole/min/g). The zero time in the fire in- 
dicates the time of addition of lactate (2 mM). After a 20 min 
perfusion with substrate, octanoate was introduced from an 
infusion pump to deliver the indicated concentrations at the 
portal vein input. Points plotted are means k S.E.M. (vertical 
bars) for 6 livers in (A) and 5 in (B). 
NADH. A concentration of 8 mM &hydroxybutyrate 
caused a 50% inhibition of glucose production. In sim- 
ilar experiments with rat liver, this metabolite was 
shown to enhance gluconeogenesis [51. That the inhib- 
ition of gluconeogenesis in cat liver was due to the 
production of excess reducing equivalents is indicated 
by the reversal of the (3-hydroxybutyrate-induced in- 
hibition by the artificial electron acceptor, phenazine 
methosulfate (fig. 2). 
The results in figs. 1 and 2 are better understood 
in the light of our earlier experiments [l-4] which 
implicate mitochondrial PEPCK in gluconeogenesis. 
To evaluate the extent to which this enzyme contri- 
butes to overall gluconeogenesis, the cytosolic forma- 
Fig. 2. Reversal of P-hydroxybutyrate-induced inhibition of 
glucogenesis n cat liver by phenazine methosulfate (PMS). 
Livers were perfused as described in the legend to fig. 1. P- 
Hydroxybutyrate and PMS were introduced as indicated. 
PMS (8 MM) had no effect on glucose production from lac- 
tate alone, Points plotted are means * S.E.M. (vertical bars) 
for 4 livers. 
tion of PEP via cytosolic oxalacetate can be blocked 
by the use of aminooxyacetate, an inhibitor of aspar- 
tate aminotransferase [111. Fig. 3 shows that in the 
presence of 0.2 mM aminooxyacetate, glucose produc- 
tion from lactate was inhibited by about 60% in cat 
liver whereas in rat liver, which has negligible activity 
of mitochondrial PEPCK, gluconeogenesis was inhib- 
ited by more than 90%. In livers from fed cats in which 
the cytosolic activity of PEPCK is much smaller than 
in the fasting condition [7] the inhibition by amino- 
oxyacetate was only 20-30%. 
281 
Volume 31, number 3 FEBS LETTERS May 1973 
f 201 ^ :‘.“:_“_x~‘_x_~ , . / 
(3 O 5 IO 15 20 25 30 
TIME(min) 
Fig. 3. A comparison of the effect of aminooxyacetic acid on 
gluconeogenesis from lactate in the perfused liver of the cat 
(o-o-o) and the rat (X-X-X). Aminooxyacetate was 
maintained at 0.2 mM by constant infusion. The closed circles 
(o-o-o) represent perfusions with livers from fed cats. Val- 
ues plotted are means for 4-6 experiments. 
4. Discusssion 
In isolated mitochondria from the guinea pig or 
rabbit liver [2, 31 decreasing the proportion of NAD+ 
relative to NADH lowers the steady state concentra- 
tion of oxalacetate within the matrix space by the inter- 
action of the NAD+/NADH ratio with malate dehydro- 
genase [ 121. Consequently, the rate of mitochondrial 
PEP synthesis falls. Jomain-Baum and Hanson [4] have 
recently reported an inhibition of PEP formation in 
isolated human liver mitochondria by octanoate at a 
concentration (0.2 mM) which inhibits gluconeo- 
genesis in the perfused guinea pig liver [5]. The inhib- 
ition of gluconeogenesis in the perfused cat liver by 
mitochondrially-generated NADH (figs. 1 and 2) is 
similar to the effect of fatty acids on gluconeogenesis 
in the perfused guinea pig liver [S, 131. These data 
support the contention that the oxidation-reduction 
state of the NAD+-system in the mitochondria is of 
significant regulatory importance for overall hepatic 
glucose production in mammalian species which have 
substantial capacity for mitochondrial PEP formation. 
Similar results are obtained irrespective of the dietary 
habit of the animal. For example, fatty acids have also 
been reported to inhibit glucose production in porto- 
caval shunted dogs [ 141. The mitochondrial content 
of hepatic PEPCK in the dog [ 151 is similar to that of 
the guinea pig. In the rat, an animal that has been ex- 
tensively used as a model for studying gluconeogenesis 
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[ 16, 171, mitochondrial reducing equivalents have a stim- 
ularory influence on glucose production [5, 18-201. 
The almost identical response to fatty acids by mito- 
chondria from both human and guinea pig liver [4] 
suggests that fatty acids may inhibit hepatic gluconeo- 
genesis in the human. 
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